Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!

Prolactin (PRL) is an exceptional hormone of pituitary gland with important implications for normal reproduction as well as for sexual behavior. It increases in the first trimester of pregnancy (physiological hyperprolactinemia). The objective of this study is to evaluate the usefulness of LL-HPRL a...

Full description

Bibliographic Details
Main Authors:	Allow, Ahmed Kaid Naji, Abdulmogny, A. Sadek S.M., Maryam, Bracamonte, Ahmed Kaid, Belqees
Format:	Article
Language:	English
Published:	Medwell Journals 2015
Subjects:	R Medicine (General) RG Gynecology and obstetrics
Online Access:	http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/1/54246_Late%20Luteal%20Hyperprolactinemia.pdf

id	iium-54246
recordtype	eprints
spelling	iium-542462017-07-14T01:05:03Z http://irep.iium.edu.my/54246/ Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!! Allow, Ahmed Kaid Naji Abdulmogny, A. Sadek S.M. Maryam, Bracamonte Ahmed Kaid, Belqees R Medicine (General) RG Gynecology and obstetrics Prolactin (PRL) is an exceptional hormone of pituitary gland with important implications for normal reproduction as well as for sexual behavior. It increases in the first trimester of pregnancy (physiological hyperprolactinemia). The objective of this study is to evaluate the usefulness of LL-HPRL as an indicator for early ongoing pregnancy in patients undergoing treatment for infertility. This is a retrospective study on one hundred and eleven women who had beenundergoing treatment for infertilityand their husbands were known to be reproductively fertile. Women with knownother causesof infertility, besides anovulation and luteal phase deficiency were excluded from the study population. They were divided into two groups matched for age and Body-Mass Index (BMI); control group A: 76 pregnant women on no anti-LF-HPRL therapy and study group B: 35 pregnant women on anti-LF-HPRL therapy. All women in both groups had been treated for hyperprolactinemia until their PRL levels were normal. Later, after one menstrual cycle, both groups had been enrolled in a Controlled Ovarian hyperstimulation (COS) Program. The COS aimed to induce 2-3 mature follicles/women/cycle. Duringthe study period (34 months), the ovulation, pregnancy, abortion and live-birth rates were evaluated. The withdrawal rate of patients was also recorded. No significant differences were observed between the two groups of women regarding baseline hormonal levels (FSH, LH, LH/FSH, testosterone, estradiol and PRL (p<0.03). However, the progesterone levels at day 21 of the cycle was significantly different between study and control groups (4.52±4.91 and 5.36±4.73, respectively, p<0.02). The serum PRL at 28th day of ovulation induction cycle was significantly different between the study and control groups (28.32±11.89 and 7.53±5.69, respectively, p<0.001). The ovulation, ongoing pregnancy, life-birth rates were significantly higher in the study group in comparison to control group (p<0.001). Early abortion and cancelation rates were significantly higher in control than in study group (p<0.001). High serum prolactin levels in the Late Follicular menstrual Phase (LF-HPRL) in infertile women treated by ovulation induction after having completed therapy for hyperprolactinemia is an early indicator for diagnosis of ongoing pregnancy, consequently treatment of LF-HPRL is not recommended. Medwell Journals 2015-10-27 Article PeerReviewed application/pdf en http://irep.iium.edu.my/54246/1/54246_Late%20Luteal%20Hyperprolactinemia.pdf Allow, Ahmed Kaid Naji and Abdulmogny, A. Sadek S.M. and Maryam, Bracamonte and Ahmed Kaid, Belqees (2015) Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!! Agricultural Journal, 10 (1). pp. 7-11. ISSN 1816-9155 http://docsdrive.com/pdfs/medwelljournals/aj/2015/7-11.pdf 10.3923/aj.2015.7.11
repository_type	Digital Repository
institution_category	Local University
institution	International Islamic University Malaysia
building	IIUM Repository
collection	Online Access
language	English
topic	R Medicine (General) RG Gynecology and obstetrics
spellingShingle	R Medicine (General) RG Gynecology and obstetrics Allow, Ahmed Kaid Naji Abdulmogny, A. Sadek S.M. Maryam, Bracamonte Ahmed Kaid, Belqees Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
description	Prolactin (PRL) is an exceptional hormone of pituitary gland with important implications for normal reproduction as well as for sexual behavior. It increases in the first trimester of pregnancy (physiological hyperprolactinemia). The objective of this study is to evaluate the usefulness of LL-HPRL as an indicator for early ongoing pregnancy in patients undergoing treatment for infertility. This is a retrospective study on one hundred and eleven women who had beenundergoing treatment for infertilityand their husbands were known to be reproductively fertile. Women with knownother causesof infertility, besides anovulation and luteal phase deficiency were excluded from the study population. They were divided into two groups matched for age and Body-Mass Index (BMI); control group A: 76 pregnant women on no anti-LF-HPRL therapy and study group B: 35 pregnant women on anti-LF-HPRL therapy. All women in both groups had been treated for hyperprolactinemia until their PRL levels were normal. Later, after one menstrual cycle, both groups had been enrolled in a Controlled Ovarian hyperstimulation (COS) Program. The COS aimed to induce 2-3 mature follicles/women/cycle. Duringthe study period (34 months), the ovulation, pregnancy, abortion and live-birth rates were evaluated. The withdrawal rate of patients was also recorded. No significant differences were observed between the two groups of women regarding baseline hormonal levels (FSH, LH, LH/FSH, testosterone, estradiol and PRL (p<0.03). However, the progesterone levels at day 21 of the cycle was significantly different between study and control groups (4.52±4.91 and 5.36±4.73, respectively, p<0.02). The serum PRL at 28th day of ovulation induction cycle was significantly different between the study and control groups (28.32±11.89 and 7.53±5.69, respectively, p<0.001). The ovulation, ongoing pregnancy, life-birth rates were significantly higher in the study group in comparison to control group (p<0.001). Early abortion and cancelation rates were significantly higher in control than in study group (p<0.001). High serum prolactin levels in the Late Follicular menstrual Phase (LF-HPRL) in infertile women treated by ovulation induction after having completed therapy for hyperprolactinemia is an early indicator for diagnosis of ongoing pregnancy, consequently treatment of LF-HPRL is not recommended.
format	Article
author	Allow, Ahmed Kaid Naji Abdulmogny, A. Sadek S.M. Maryam, Bracamonte Ahmed Kaid, Belqees
author_facet	Allow, Ahmed Kaid Naji Abdulmogny, A. Sadek S.M. Maryam, Bracamonte Ahmed Kaid, Belqees
author_sort	Allow, Ahmed Kaid Naji
title	Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
title_short	Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
title_full	Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
title_fullStr	Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
title_full_unstemmed	Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!
title_sort	late luteal hyperprolactinemia (ll-hprl) is not a disease..!!!
publisher	Medwell Journals
publishDate	2015
url	http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/ http://irep.iium.edu.my/54246/1/54246_Late%20Luteal%20Hyperprolactinemia.pdf
first_indexed	2023-09-18T21:16:45Z
last_indexed	2023-09-18T21:16:45Z
_version_	1777411613774577664

Late Luteal Hyperprolactinemia (LL-HPRL) is not a disease..!!!

Similar Items